Prelude Therapeutics Inc (PRLD): 10 insider purchases in the last two years (4 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Mar 27, 2025 | Vaddi Krishna Director, Officer | 675,000 | $0.69 | $465.7K | opportunistic |
| Mar 27, 2025 | Combs Andrew Officer | 100,000 | $0.69 | $69.0K | no history |
| Mar 24, 2025 | Vaddi Krishna Director, Officer | 20,416 | $0.73 | $14.9K | opportunistic |
| Mar 18, 2025 | Vaddi Krishna Director, Officer | 39,105 | $0.75 | $29.3K | opportunistic |
| Mar 14, 2025 | Vaddi Krishna Director, Officer | 97,500 | $0.72 | $69.7K | opportunistic |
| Jan 3, 2025 | Vaddi Krishna Director, Officer | 5,000 | $1.21 | $6.0K | no history |
| Jan 2, 2025 | Vaddi Krishna Director, Officer | 10,000 | $1.20 | $12.0K | no history |
| Dec 26, 2024 | Combs Andrew Officer | 63,075 | $1.36 | $85.7K | no history |
| Dec 20, 2024 | Vaddi Krishna Director, Officer | 106,888 | $0.93 | $99.1K | no history |
| Dec 20, 2024 | Lim Bryant David Officer | 25,000 | $0.91 | $22.8K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.